Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/5/2025

Cerebral Amyloid Angiopathy: Diagnosis and Management

Location and Imaging Characteristics

  • Lobar hemorrhages in elderly nonhypertensive patients are characteristically due to cerebral amyloid angiopathy (CAA), whereas deep hemorrhages in hypertensive patients typically result from chronic hypertension 1

  • Multiple juxtacortical microhemorrhages on susceptibility-weighted MRI sequences are highly specific for CAA and represent chronic hemorrhagic lesions from amyloid deposition in vessel walls 2, 3

Patient Demographics and Clinical Context

  • Short-term memory loss is commonly associated with CAA due to shared pathophysiology involving β-amyloid deposition 4

Differential Diagnosis

  • Hypertensive hemorrhages typically occur in deep structures (basal ganglia, thalamus, pons, cerebellum) from rupture of penetrating subcortical vessels, not in lobar locations 1

  • The presence of multiple cortical microhemorrhages argues against isolated hypertensive arteriopathy 2

  • Hemorrhagic metastases would typically show surrounding vasogenic edema or an identifiable mass 3

  • Cerebral vein thrombosis would present with venous infarction with hemorrhagic transformation rather than isolated lobar hemorrhage 2

  • Vertebral artery dissection would cause posterior circulation ischemia or subarachnoid hemorrhage, not isolated occipital parenchymal hemorrhage 2

Risk of Recurrence and Anticoagulation

  • CAA-associated hemorrhages have an increased risk of recurrence compared to other intracerebral hemorrhage etiologies, particularly in lobar locations 6

  • Decision analysis studies recommend against anticoagulation in patients with lobar intracerebral hemorrhage, even in the presence of atrial fibrillation 7, 6

Blood Pressure Management

  • The underlying CAA pathology requires different long-term blood pressure management considerations than hypertensive arteriopathy 2